Just watching the ebb and flow today. Joe has t
Post# of 36533
(Total Views: 345)
Posted On: 06/30/2020 1:34:43 PM
Just watching the ebb and flow today.
Joe has the fiscal resources now to prepare some of the subsidiaries to generate revenue. He can also complete some important acquisitions which have decent potential. I hope to hear about these important steps to grow GNBT. In this moment there is so much potential.
In re Nugenerex, initially it’s all about the peptides and whether there is evidence that they’ll ‘work’. I hope they do...it’s a long shot, really...yes I hope they work and drive increasing value in the stock price. But more importantly, we...need...a...vaccine. C’mon Joe, bring this one home. Make it the defining contribution of your life.
Beyond the immediate vaccine development opportunity lie the remainder of the new company’s potential including cancer vaccines. that’s where the real long term value is to be found.
A Nugenerex CC scheduled for July 10. I’m looking for a Generex CC not long after.
Let’s just get on with it.
Joe has the fiscal resources now to prepare some of the subsidiaries to generate revenue. He can also complete some important acquisitions which have decent potential. I hope to hear about these important steps to grow GNBT. In this moment there is so much potential.
In re Nugenerex, initially it’s all about the peptides and whether there is evidence that they’ll ‘work’. I hope they do...it’s a long shot, really...yes I hope they work and drive increasing value in the stock price. But more importantly, we...need...a...vaccine. C’mon Joe, bring this one home. Make it the defining contribution of your life.
Beyond the immediate vaccine development opportunity lie the remainder of the new company’s potential including cancer vaccines. that’s where the real long term value is to be found.
A Nugenerex CC scheduled for July 10. I’m looking for a Generex CC not long after.
Let’s just get on with it.
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼